Shareholding disclosure

Martin und Rosmarie Ebner

Declared position

Threshold

Fell below threshold

Timeline

Published

22.12.2021

Transaction

14.12.2021

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TALCK00049

Beneficial owner

Martin und Rosmarie Ebner

Declared address

Martin und Rosmarie Ebner, 8832 Wilen

Verpflichtung zur Annahme eines öffentlichen Kaufangebotes

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Martin und Rosmarie Ebner

Vifor Pharma AG22.12.2021TALCK00049

Disclosure summary

Martin und Rosmarie Ebner disclosed a holding in Vifor Pharma AG that fell below the publication threshold, published by SIX Exchange Regulation on 22.12.2021, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Martin und Rosmarie Ebner disclosed a holding in Vifor Pharma AG, published on 22.12.2021.

Publication date22.12.2021

Transaction date14.12.2021

Issuing companyVifor Pharma AG

Beneficial ownerMartin und Rosmarie Ebner

Declared addressMartin und Rosmarie Ebner, 8832 Wilen

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTALCK00049

Conditions

Verpflichtung zur Annahme eines öffentlichen Kaufangebotes

Source: SIX Exchange Regulation · Publication date: 22.12.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open